ArticleOncotarget2018

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.

Zhi-Xian Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.